| Filed On | Filing |
|---|---|
| 25 Sep 2026 |
Form 4: Walbert Keli, Director
Granted 36,000 Stock Option (Right to Buy) |
| 17 Jun 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others
Bought 6,146 shares ($153K) · Bought 61,523 shares ($1.54M) |
| 21 May 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others
Bought 3,802 shares ($94.9K) · Bought 996 shares ($24.8K) |
| 14 May 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others
Bought 6,387 shares ($159K) |
| 11 May 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others
Bought 9,906 shares ($242K) · Bought 1,483 shares ($37K) · Bought 39,869 shares ($989K) |
| 06 May 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., Director and 5 others
Received 4,838,086 shares by conversion · Bought 2,675,000 shares ($48.2M) · Bought 97,411 shares ($2.4M) · 1 more |
| 06 May 2026 |
Form 4: Novo Holdings A/S, 10% owner
Received 4,180,550 shares by conversion |
| 04 May 2026 |
Form 4: Maraganore John, Director
Granted 107,338 Warrants (Right to Buy) · Received 35,948 shares by conversion |
| 04 May 2026 |
Form 4: Madigan Catherine, Chief Medical Officer
Granted 145,134 Warrants (Right to Buy) · Granted 49,016 Stock Option (Right to Buy) |
| 04 May 2026 |
Form 4: Behrndt-Eriksen Mads Nikolaj, See Remarks
Granted 195,206 Warrants (Right to Buy) · Granted 49,016 Stock Option (Right to Buy) |
Loading...